FDA & Health Canada suspend marketing of Trasylol in United State and Canada
2007-11-11
November, 5 , 2007, US FDA and Health Canada the American's and Canadian equivalent to the Saudi Food and Drug Authority (SFDA) , announced that at the request of Health Canada and US FDA , the manufacturer Bayer Inc. has temporarily suspended marketing of the drug Trasylol (Aprotinin) pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.
Trasylol (Aprotinin) is drug used to control bleeding during heart surgery and reduce the need for blood transfusion.